Loading clinical trials...
Loading clinical trials...
A Single Dose, Non-randomised, Open-label, Parallel Group Study to Assess the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Participants With Severe Renal Impairment, End-stage Kidney Disease, and in Healthy Participants
Conditions
Interventions
AZD4144
Locations
2
Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Bucharest, Romania
Start Date
November 18, 2024
Primary Completion Date
April 23, 2025
Completion Date
April 23, 2025
Last Updated
April 7, 2026
NCT07310901
NCT06342713
NCT07471204
NCT07401472
NCT07154901
NCT07231497
Lead Sponsor
AstraZeneca
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions